Dr. Jiachen Shen | Nanomedicine | Best Researcher Award

Dr. Jiachen Shen | Nanomedicine | Best Researcher Award

Dr. Jiachen Shen | Harbin Medical University | China

Academic Background

Dr. Jiachen Shen is a doctoral student at Harbin Medical University, specializing in nanomedicine. Their research portfolio includes multiple peer-reviewed publications in high-impact journals, with significant contributions to the field of drug delivery systems. Dr. Shen’s work has been cited extensively, with 37 citations recorded across documents, demonstrating recognition and influence within the scientific community. Their research output is indexed in major databases including Scopus and Google Scholar, reflecting a growing h-index that underscores their consistent contribution to advancing biomedical nanotechnology.

Research Focus

Dr. Shen’s research primarily focuses on nanomedicine, specifically the development and optimization of mesoporous silica nanoparticles as carriers for therapeutic agents. Their work aims to enhance targeted drug delivery and improve efficacy in treating diseases associated with abnormal vascular growth. Through surface modification and pore size regulation of nanoparticles, Dr. Shen explores innovative strategies to overcome current limitations in anti-vascular therapies.

Work Experience

As a doctoral student, Dr. Shen has actively led laboratory experiments and coordinated research projects from conceptualization to publication. They have collaborated with the Faculty of Life Science and Medicine at Harbin Institute of Technology, fostering cross-institutional research efforts. This hands-on experience has strengthened their expertise in nanomaterials, experimental design, and scientific communication.

Key Contributions

Dr. Shen has been instrumental in designing and executing complex research experiments, particularly in the project focusing on mesoporous silica nanoparticles as functional carriers for anti-vascular migration therapies. They have organized research strategies, aligned experimental designs with study objectives, and created detailed visual representations of nanoparticle structures and mechanisms. These contributions have enabled clear communication of research findings and facilitated the successful publication of their work in respected journals.

Awards & Recognition

Dr. Shen’s work has earned them nomination for the Best Researcher Award, reflecting recognition of their innovative contributions and scientific impact within the field of nanomedicine.

Professional Roles & Memberships

Although Dr. Shen is at an early stage in their career, they have actively engaged in collaborative research efforts, contributing to team projects and supporting knowledge exchange across institutions. Their growing professional network highlights a commitment to scientific collaboration and knowledge dissemination.

Profile

Scopus

Featured Publications

Guo, R., Zhang, X., Song, Y., Shen, J., Li, K., Zheng, Y. Surface Modification and Pore Size Regulation of MSN as Functional Aflibercept Carrier for Anti-Vascular Migration. Materials.

Impact Statement / Vision

Dr. Shen envisions advancing nanomedicine by developing highly efficient drug delivery systems that improve therapeutic outcomes for patients with vascular-related diseases. Their work bridges fundamental research and clinical applications, aiming to create innovative solutions that address critical challenges in modern medicine and contribute to global healthcare advancement.

Krittawan Tongkanarak | Drug Delivery System | Young Researcher Award

Dr. Krittawan Tongkanarak | Drug Delivery System | Young Researcher Award

Lecturer | Prince of Songkla University | Thailand

Dr. Krittawan Tongkanarak is a pharmacist, lecturer, and researcher in pharmaceutical sciences, specializing in drug delivery systems and pharmaceutical aerosols. She has built her academic and professional career at the Prince of Songkla University, where she contributes to both teaching and research. With expertise in pulmonary drug delivery systems and a strong background in advanced laboratory techniques, she is committed to developing innovative solutions for drug formulations. Her academic journey and professional experience reflect dedication to addressing global health challenges, particularly in improving therapeutic outcomes for respiratory diseases through advanced pharmaceutical technologies.

Publication Profile

Scopus

ORCID

Education Background

Dr. Krittawan Tongkanarak earned her Doctor of Pharmacy degree with First Class Honors, establishing a strong foundation in pharmacy and drug sciences. She further advanced her academic journey by pursuing a doctoral degree in pharmaceutical sciences, where she focused on innovative drug delivery technologies and their applications in healthcare. Her education was enriched through international exposure and collaboration with experts in the field of pharmaceutical technology. This solid academic background has provided her with both theoretical knowledge and practical skills that continue to guide her teaching and research in pharmaceutical sciences today.

Professional Experience

Her professional career spans both academic and practical pharmacy roles, contributing to her well-rounded expertise. She has worked as a drugstore pharmacist, gaining valuable insights into patient care and medication management. She later advanced into academic roles, serving as a lecturer at the Faculty of Pharmaceutical Sciences, Prince of Songkla University, where she also carried out impactful research. In addition, she has contributed as a postdoctoral researcher at the Drug Delivery System Excellence Center, focusing on advanced drug delivery platforms. Her career reflects a seamless blend of practice, research, and teaching, demonstrating a commitment to advancing pharmaceutical science.

Awards and Honors

Dr. Krittawan Tongkanarak has been recognized for her academic excellence and research contributions through prestigious scholarships and honors. She was awarded the Royal Golden Jubilee Ph.D. Programme scholarship, a highly competitive program that supports outstanding doctoral researchers in Thailand. This achievement highlights her strong research capabilities and dedication to contributing meaningfully to pharmaceutical sciences. Such recognition not only underscores her academic accomplishments but also demonstrates the impact of her work on both national and international platforms, inspiring further advancements in drug delivery and pharmaceutical technology through her professional and research endeavors.

Research Focus

Her research primarily centers on pharmaceutical technology, with a strong emphasis on aerosol science and pulmonary drug delivery systems. She is particularly interested in developing novel drug formulations to improve treatment outcomes for diseases such as tuberculosis and respiratory-related conditions. Her work includes the design and evaluation of proliposomal powders, microemulsions, and biomolecular interactions of drug compounds with human proteins. By combining experimental research with molecular docking approaches, she advances understanding of pharmacokinetics and pharmacodynamics in drug delivery. Her contributions address critical challenges in healthcare, promoting innovation in respiratory drug therapies and pharmaceutical formulation development.

Publication Top Notes

  • Evaluating the biomolecular interaction between delamanid/formulations and human serum albumin by fluorescence, CD spectroscopy and SPR: Effects on protein conformation, kinetic and thermodynamic parameters
    Published Year: 2024
    Citation:

  • Delamanid proliposomal powder aerosols targeting alveolar macrophages for treatment of pulmonary extensively drug-resistant tuberculosis treatment: Bioactivity, biocompatibility, and structure elucidation
    Published Year: 2024
    Citation:

  • Metabolism of Cannabidiol in Respiratory-Associated Cells and HepG2-Derived Cells and Molecular Docking of Cannabidiol and Its Metabolites with CYP Enzymes and Cannabinoid Receptors
    Published Year: 2025
    Citation:

  • Antimycobacterial and autophagic activity of nebulized delamanid microemulsion targeting alveolar macrophage
    Published Year: 2025
    Citation:

Conclusion

Dr. Krittawan Tongkanarak’s career is a testament to her dedication to pharmaceutical research and education. With a solid academic foundation, practical experience, and recognized achievements, she continues to make meaningful contributions to drug delivery sciences. Her research not only enhances therapeutic approaches for respiratory diseases but also inspires future advancements in pharmaceutical technologies. By combining her expertise as a pharmacist, educator, and researcher, she stands as a promising figure in pharmaceutical sciences whose work is shaping innovative solutions for improving patient care and treatment outcomes.